DK175113B1 - Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV - Google Patents

Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV Download PDF

Info

Publication number
DK175113B1
DK175113B1 DK198807081A DK708188A DK175113B1 DK 175113 B1 DK175113 B1 DK 175113B1 DK 198807081 A DK198807081 A DK 198807081A DK 708188 A DK708188 A DK 708188A DK 175113 B1 DK175113 B1 DK 175113B1
Authority
DK
Denmark
Prior art keywords
dideoxy
imino
compound
methyl
hiv
Prior art date
Application number
DK198807081A
Other languages
Danish (da)
English (en)
Other versions
DK708188D0 (da
DK708188A (da
Inventor
Raymond Allen Dwek
Thomas William Rademacher
Georg William John Fleet
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK708188D0 publication Critical patent/DK708188D0/da
Publication of DK708188A publication Critical patent/DK708188A/da
Application granted granted Critical
Publication of DK175113B1 publication Critical patent/DK175113B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK198807081A 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV DK175113B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13621987A 1987-12-21 1987-12-21
US13621987 1987-12-21
US24914488 1988-09-26
US07/249,144 US4999360A (en) 1987-12-21 1988-09-26 Method of inhibiting virus

Publications (3)

Publication Number Publication Date
DK708188D0 DK708188D0 (da) 1988-12-20
DK708188A DK708188A (da) 1989-06-22
DK175113B1 true DK175113B1 (da) 2004-06-07

Family

ID=26834131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198807081A DK175113B1 (da) 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV

Country Status (16)

Country Link
US (1) US4999360A (no)
EP (1) EP0322395B1 (no)
JP (1) JP2538014B2 (no)
KR (1) KR910009994B1 (no)
AT (1) ATE87206T1 (no)
AU (1) AU607834B2 (no)
CA (1) CA1316929C (no)
DE (1) DE3879653T2 (no)
DK (1) DK175113B1 (no)
FI (1) FI93210C (no)
IE (1) IE63095B1 (no)
IL (1) IL88742A (no)
NO (1) NO172340C (no)
NZ (1) NZ227410A (no)
OA (1) OA08937A (no)
PT (1) PT89267B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925940T2 (de) * 1988-11-03 1996-10-24 Searle & Co Dideoxy-L-arabinitol Derivate als Antivirus-Verbindungen
US4894388A (en) * 1988-12-22 1990-01-16 Monsanto Company Glycosidase inhibitors and use thereof
US5100797A (en) * 1989-06-27 1992-03-31 Monsanto Company Fucosidase inhibitors
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
GB9026271D0 (en) * 1990-12-03 1991-01-16 Alphey Thomas J W Control of parasitic nematodes(a)
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
CZ120398A3 (cs) * 1995-09-08 1998-12-16 Novo Nordisk A/S Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty
CN102399228B (zh) * 2010-09-08 2013-10-16 中国科学院成都生物研究所 N-烷基多羟基哌啶衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Also Published As

Publication number Publication date
NO885655L (no) 1989-06-22
FI885880A0 (fi) 1988-12-20
DK708188D0 (da) 1988-12-20
FI93210C (fi) 1995-03-10
CA1316929C (en) 1993-04-27
FI93210B (fi) 1994-11-30
KR910009994B1 (ko) 1991-12-10
IL88742A0 (en) 1989-07-31
JP2538014B2 (ja) 1996-09-25
IE883794L (en) 1989-06-21
JPH01230517A (ja) 1989-09-14
EP0322395B1 (en) 1993-03-24
FI885880A (fi) 1989-06-22
NO172340C (no) 1993-07-07
NZ227410A (en) 1991-06-25
DE3879653T2 (de) 1993-10-14
OA08937A (fr) 1989-10-31
IE63095B1 (en) 1995-03-22
PT89267A (pt) 1989-12-29
PT89267B (pt) 1993-12-31
AU2706888A (en) 1989-06-22
KR890009389A (ko) 1989-08-01
DE3879653D1 (de) 1993-04-29
US4999360A (en) 1991-03-12
AU607834B2 (en) 1991-03-14
EP0322395A1 (en) 1989-06-28
DK708188A (da) 1989-06-22
NO172340B (no) 1993-03-29
NO885655D0 (no) 1988-12-20
IL88742A (en) 1993-08-18
ATE87206T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
DK175113B1 (da) Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV
CN113015726B (zh) 酮酰胺类化合物及其制备方法、药物组合物和用途
US5030638A (en) Method of antiviral enhancement
DK174627B1 (da) Forbindelse, farmaceutisk præparat, lægemiddel og anvendelse af 3'-deoxythymidin-2'-en til fremstilling af et farmaceutisk præparat til behandling af retrovirusinfektioner
AU596864B2 (en) The use of 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'- didehydrocytidine) in treating patients infected with retroviruses
FR2614533A1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
KR20000065885A (ko) 항바이러스성 피리미딘다이온 유도체 및 그 제조방법
US5089520A (en) Method of inhibiting virus
JPH02180A (ja) 2,2‐ジメチルクロメン誘導体、その製造方法及びこれを含む薬剤組成物
US5043416A (en) Method of inhibiting virus
CN104876950A (zh) 一种含硫稠杂四环氮杂糖衍生物及其制备方法和应用
Sochacka et al. Nucleosides. 153. Synthesis of 1-methyl-5-(3-azido-2, 3-dideoxy-. beta.-D-erythro-pentofuranosyl) uracil and 1-methyl-5-(3-azido-2, 3-dideoxy-2-fluoro-. beta.-D-arabinofuranosyl) uracil. The C-nucleoside isostere of 3'-azido-3'-deoxythymidine and its 2'-" up"-fluoro analog
WO1996007409A1 (en) Alkaloids and their antiviral agents
KR950013764B1 (ko) 피로글루타미드 유도체, 그 제조방법, 및 그것을 함유하는 치매증 치료제
JPH07504405A (ja) 置換アザスピラン化合物の投与によるhiv個体aidsの遅延方法
KR810000892B1 (ko) 1,3-디하이드로스피로 [이소벤조푸란-1,4'-피페리딘]류의 제조방법
EP0769496A1 (en) Novel 2,3-dihydrobenzofuran derivative, process for producing the same, and use thereof
FR2655649A1 (fr) Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US6001818A (en) Use of 2',3'-dideoxycytidin-2'-ene (2'- ,3'-dideoxy-2'3'-didehydrocytidine) in treating patients infected with retroviruses
EP0260605A2 (en) Dihydropyridine-5-phosphonic acid cyclic ester
CN114456190A (zh) 卡山烷二萜phanginin A衍生物及其药物组合物和其应用
AU7595998A (en) Sulfate salt of an HIV protease inhibitor having an improved oral absorption and bioavailability
WO1993001193A1 (en) Marine compounds as hiv inhibitors
CZ335095A3 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
CZ335595A3 (en) N-substituted azaheterocyclic carboxylic acids and their esters, process of their preparation and pharmaceutical compositions containing thereof

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK